{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Managing Dyslipidemia for CVD Prevention: A Review of the Recent Clinical Practice Guidelines

Activity Steps

Purpose of Activity

To provide information on the most recent CPG from the AACE/ACE on the management of dyslipidemia for ASCVD prevention.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify ASCVD risk as outlined in the AACE/ACE CPG.
  2. Examine the goals and management for patients with ASCVD and ASCVD risk.
Price: $17.95


  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP0119
Published: Jan 2019
Expires: 12/4/2020
Collections: Heart Health
Required Passing Score: 13/18 (72%)
Authors: Nicole A. Ciffone, MSN, ANP-C, AACC, CLS, FNLA; Tina Copple, DNP, BC-ADM, CDE, CLS